Literature DB >> 10731045

Chloroquine blocks the background potassium current in guinea pig atrial myocytes.

D E Benavides-Haro1, J A Sánchez-Chapula.   

Abstract

In this study we examined the effects of chloroquine on the muscarinic potassium current, I(K-ACh), and the inward rectifying potassium current, I(K1). We utilized three ways to induce I(K-ACh): activating the M2-muscarinic receptors with carbachol, activating the purinergic A1-receptors with adenosine and directly activating the G(K)-protein coupled with these receptors in an irreversible way with GTPgammaS. In experiments using the whole-cell configuration of the patch-clamp technique, we found that chloroquine, independently from the manner of activation of I(K-ACh), was able to block this current with similar potency. These results strongly suggest that chloroquine may be acting directly on the muscarinic potassium channel. Chloroquine also blocked I(K1) with similar potency, in both guinea pig atrial and ventricular myocytes.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10731045     DOI: 10.1007/s002109900185

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  11 in total

1.  Specific residues of the cytoplasmic domains of cardiac inward rectifier potassium channels are effective antifibrillatory targets.

Authors:  Sami F Noujaim; Jeanne A Stuckey; Daniela Ponce-Balbuena; Tania Ferrer-Villada; Angelica López-Izquierdo; Sandeep Pandit; Conrado J Calvo; Krzysztof R Grzeda; Omer Berenfeld; José A Sánchez Chapula; José Jalife
Journal:  FASEB J       Date:  2010-06-28       Impact factor: 5.191

2.  The voltage-sensitive cardiac M2 muscarinic receptor modulates the inward rectification of the G protein-coupled, ACh-gated K+ current.

Authors:  Pedro D Salazar-Fajardo; Iván A Aréchiga-Figueroa; Ana Laura López-Serrano; Julio C Rodriguez-Elias; Javier Alamilla; José A Sánchez-Chapula; Martin Tristani-Firouzi; Ricardo A Navarro-Polanco; Eloy G Moreno-Galindo
Journal:  Pflugers Arch       Date:  2018-08-28       Impact factor: 3.657

3.  Chloroquine blocks a mutant Kir2.1 channel responsible for short QT syndrome and normalizes repolarization properties in silico.

Authors:  Angelica Lopez-Izquierdo; Daniela Ponce-Balbuena; Tania Ferrer; Frank B Sachse; Martin Tristani-Firouzi; Jose A Sanchez-Chapula
Journal:  Cell Physiol Biochem       Date:  2009-08-03

4.  The molecular basis of chloroquine block of the inward rectifier Kir2.1 channel.

Authors:  Aldo A Rodríguez-Menchaca; Ricardo A Navarro-Polanco; Tania Ferrer-Villada; Jason Rupp; Frank B Sachse; Martin Tristani-Firouzi; José A Sánchez-Chapula
Journal:  Proc Natl Acad Sci U S A       Date:  2008-01-23       Impact factor: 11.205

5.  Molecular mechanisms of chloroquine inhibition of heterologously expressed Kir6.2/SUR2A channels.

Authors:  Daniela Ponce-Balbuena; Aldo A Rodríguez-Menchaca; Angélica López-Izquierdo; Tania Ferrer; Harley T Kurata; Colin G Nichols; José A Sánchez-Chapula
Journal:  Mol Pharmacol       Date:  2012-07-31       Impact factor: 4.436

6.  Phase I randomized dose-ascending placebo-controlled trials of ferroquine--a candidate anti-malarial drug--in adults with asymptomatic Plasmodium falciparum infection.

Authors:  Ghyslain Mombo-Ngoma; Christian Supan; Matthias P Dal-Bianco; Michel A Missinou; Pierre-Blaise Matsiegui; Carmen L Ospina Salazar; Saadou Issifou; Daniel Ter-Minassian; Michael Ramharter; Maryvonne Kombila; Peter G Kremsner; Bertrand Lell
Journal:  Malar J       Date:  2011-03-01       Impact factor: 2.979

7.  Randomized dose-ranging controlled trial of AQ-13, a candidate antimalarial, and chloroquine in healthy volunteers.

Authors:  Fawaz Mzayek; Haiyan Deng; Frances J Mather; Elizabeth C Wasilevich; Huayin Liu; Christiane M Hadi; David H Chansolme; Holly A Murphy; Bekir H Melek; Alan N Tenaglia; David M Mushatt; Albert W Dreisbach; Juan J L Lertora; Donald J Krogstad
Journal:  PLoS Clin Trials       Date:  2007-01-05

Review 8.  Cardiac effects and toxicity of chloroquine: a short update.

Authors:  Kanigula Mubagwa
Journal:  Int J Antimicrob Agents       Date:  2020-06-19       Impact factor: 5.283

Review 9.  Drug-induced organ injury in coronavirus disease 2019 pharmacotherapy: Mechanisms and challenges in differential diagnosis and potential protective strategies.

Authors:  Mohammad Mehdi Ommati; Ali Mobasheri; Reza Heidari
Journal:  J Biochem Mol Toxicol       Date:  2021-05-11       Impact factor: 3.568

Review 10.  Cardiac potassium inward rectifier Kir2: Review of structure, regulation, pharmacology, and arrhythmogenesis.

Authors:  Louise Reilly; Lee L Eckhardt
Journal:  Heart Rhythm       Date:  2021-04-20       Impact factor: 6.343

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.